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Modulating medial septal 
cholinergic activity reduces medial 
entorhinal theta frequency without 
affecting speed or grid coding
Francis Carpenter  1,2, Neil Burgess1,3 & Caswell Barry2
Medial septal inputs to the hippocampal system are crucial for aspects of temporal and spatial 
processing, such as theta oscillations and grid cell firing. However, the precise contributions of the 
medial septum’s cholinergic neurones to these functions remain unknown. Here, we recorded neuronal 
firing and local field potentials from the medial entorhinal cortex of freely foraging mice, while 
modulating the excitability of medial septal cholinergic neurones. Alteration of cholinergic activity 
produced a reduction in the frequency of theta oscillations, without affecting the slope of the non-linear 
theta frequency vs running speed relationship observed. Modifying septal cholinergic tone in this way 
also led mice to exhibit behaviours associated with novelty or anxiety. However, grid cell firing patterns 
were unaffected, concordant with an absence of change in the slopes of the theta frequency and firing 
rate speed signals thought to be used by grid cells.
The medial septal nucleus (MS) of the basal forebrain contains a mixture of GABAergic, glutamatergic, and cho-
linergic neurones, each with projections to the hippocampus and entorhinal cortex1–4. The MS is known to play 
a key role in the temporal processing of the hippocampal formation, acting as a ‘pacemaker’ of the 6–10 Hz theta 
oscillation seen throughout the region5–11. In addition, the MS is integral to animals’ spatial and navigational 
abilities12,13, perhaps due to its encoding of the animal’s running speed in the firing rates of specific neurones14,15. 
The precise roles of the diverse neural subtypes of the MS in these processes remain largely unknown however. 
In addition, one or both of these temporal and spatial functions of the MS may account for the observation 
that its inactivation disrupts the precise periodic firing patterns of grid cells16,17. Oscillatory interference models 
imply that the septum’s temporal processing is key, in proposing that velocity-dependent changes in the differ-
ence in frequency between two theta oscillations encode the animal’s speed and heading direction, allowing for 
the appropriate updating of grid cell firing18. Alternatively, continuous attractor network models hold that the 
septum’s spatial processing is paramount. Specifically, in suggesting that an animal’s running speed is encoded in 
the firing rates of septal and thus entorhinal neurones, which, when combined with directional information, can 
be used to shift the grid cell representation of self-location19,20. At present however, it is unknown which of these 
speed signals are used to update grid firing, and thus what the precise functional contribution of the MS to grid 
cell processing is.
Evidence for involvement of the MS in theta rhythmogenesis is compelling and longstanding, with lesions 
of the MS eliminating theta oscillations, and MS neurones bursting at theta frequencies5–11. Recent results con-
sistently indicate a role for cholinergic neurones of the MS in movement-related theta oscillations, though one 
which remains largely elusive: Lesions of these neurones reduce theta power but do not abolish it21,22, optogeneti-
cally stimulating them in behaving mice spares theta frequencies while adjacent frequencies are attenuated23, and 
muscarinic receptor blockade abolishes the change in theta frequency with running speed24. However, because 
cholinergic neurones do not burst at theta frequencies, they are unlikely to be the ultimate ‘pacemakers’ of theta 
oscillations25. This function is generally attributed to the GABAergic MS neurones, which do burst at theta fre-
quencies in-vivo25, lead hippocampal theta26, and extensively contact hippocampal interneurons27, which in turn 
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pace theta oscillations28. While glutamatergic MS neurones can also pace theta oscillations14,29, this depends on 
local connectivity within the MS, probably through connections onto GABAergic neurones14. That is, the exact 
involvement of MS cholinergic neurones in movement-related theta oscillations remains to be fully characterised.
The MS has also long been known to be central to animals’ spatial and navigational capacities: lesions of the 
MS prevent rats from learning to navigate to a goal purely by its location in a room12, and impair their ability to 
navigate to a hidden goal in the Morris water maze13. More recent results suggest that the MS may contribute 
to spatial processing through encoding the animal’s running speed in the firing rates of specific neurones. For 
example, inactivation of the MS impairs animals’ ability to estimate linear distances travelled30, abolishes the 
distance-specific firing of place cells on a running wheel31, and modulates the speed-rate coding of entorhinal 
neurones32. Further, inactivation of the MS disrupts the periodic spatial firing of grid cells without affecting their 
directional tuning16,17. Indeed, firing rate coding of running speed has been observed in glutamatergic neurones 
of the MS14, as well as their entorhinal-projecting axons15. However, the extent to which cholinergic MS neurones 
are involved in the encoding of running-speed is unknown.
Given this context of uncertainty regarding the involvement of cholinergic neurones in the septum’s gen-
eration of theta oscillations and its firing rate code for running speed, we recorded single units and local field 
potentials from the medial entorhinal cortex of foraging mice while modulating the excitability of MS cholinergic 
neurones using Designer Receptors Exclusively Activated by Designer Drugs (DREADDs). As well as aiming to 
shed light on the role of cholinergic neurones in these septal functions, we hoped also to gain insight into the 
relative involvement of theta frequency and firing rate speed signals in the generation of grid cell firing patterns. 
If modulating MS cholinergic activity altered the difference between the constituent theta oscillators in how their 
frequencies varied with running speed, oscillatory interference models predict that the scale of the grid pattern 
should change18. Indeed, it is this mechanism by which increases in acetylcholine concentration in novel con-
texts have been suggested to give rise to the increase in grid scale observed when rats are first exposed to a novel 
environment33,34. Alternatively, continuous attractor network models predict that the scale of the grid pattern 
should vary if modulating MS cholinergic activity altered the slope of the firing rate vs running speed relationship 
seen in entorhinal neurones19,20. While using DREADDs to modulate MS cholinergic activity reduced the fre-
quency of theta oscillations, there was no change in the slope of the non-linear theta frequency vs running speed 
relationship observed, nor in the phase precession exhibited by entorhinal grid cells. Similarly, no change was 
observed in the relationship between firing rate and running speed in recorded grid cells. The absence of change 
in the slopes of these putative speed signals was consistent with a lack of change in grid cell firing patterns. These 
results therefore provide evidence for an involvement of MS cholinergic neurones in the determination of the 
frequency of theta oscillations, but not in the determination of theta-frequency and firing-rate speed signals, pre-
venting conclusions being drawn regarding which is central to the updating of the grid cell code for self-location. 
Interestingly, modulation of septal cholinergic activity also led mice to display a pattern of behaviours consistent 
with anxiety or the detection of novelty.
Results
To investigate the function of MS cholinergic neurones, we modulated their excitability using DREADDs, 
while recording extracellularly from grid cells in medial entorhinal cortex (Fig. 1A). The Cre-dependent 
AAV2-hSyn-DIO-hM3D(Gq)-mCherry virus was injected into the MS of ChAT-IRES-Cre mice, so as to express 
hM3Dq exclusively in cholinergic neurones of the MS. Expression of hM3Dq (a modified Gq-coupled human 
M3 muscarinic receptor) leads subsequent intraperitoneal injection of Clozapine-N-Oxide (CNO), to increase 
the excitability of hM3Dq expressing neurones35, having first been converted to Clozapine36. As such, adminis-
tration of CNO may be expected to elevate septal cholinergic activity. However, without direct recordings from 
these neurones, and given local connections from cholinergic onto GABAergic neurones within the septum37, we 
cannot conclusively state whether the DREADD manipulation ultimately resulted in a net increase or decrease 
in septal cholinergic tone, and thus simply refer to the manipulation as a modulation of cholinergic activity (see 
Discussion for further consideration of this issue). Immunohistochemical staining for Choline Acetyltransferase 
(ChAT) and mCherry confirmed that expression of hM3Dq was limited to the MS (Fig. 1B), while confocal 
imaging indicated a tight overlap in expression of ChAT and mCherry (Fig. 1C). Cell counting revealed that 
mCherry was expressed in the majority of ChAT + neurones of the MS (Supp Fig. 1D; mean ± SEM propor-
tion of ChAT + neurones co-labelled for mCherry = 0.57 ± 0.039), while almost all mCherry + neurones were 
ChAT + (Supp Fig. 1E; mean ± SEM proportion of mCherry + neurones co-labelled for ChAT = 0.95 ± 0.0032), 
indicating that hM3Dq was expressed almost exclusively in cholinergic neurones.
Electrophysiological recordings were made from the medial entorhinal cortex of 10 mice exploring a famil-
iar environment during ‘baseline’ trials and one hour after injection of either CNO (3 mg/kg) or an equivalent 
volume of saline (‘CNO probe’ and ‘saline probe’ trials respectively; see Supp Fig. 1E for full experimental proto-
col). Following injection of CNO, a clear reduction in the frequency of theta oscillations was observed (Fig. 1D), 
apparent in speed-matched LFP traces from baseline and CNO probe trials (Supp Fig. 1F). Repeated Measures 
Analysis of Variance (RM-ANOVA) was used to assess whether there was a significant difference between CNO 
and saline injections in the change in theta frequency between baseline and probe trials. Indeed, CNO signif-
icantly reduced the frequency of theta oscillations (Fig. 1F; RM-ANOVA, trial*drug interaction; F(1,9) = 15.50, 
p = 0.003), but did not affect their absolute power, nor their ‘signal to noise’ (S2N: ratio of average power in a 
2 Hz band centred on the theta peak compared to average power in the rest of the 3–25 Hz range) (Fig. 1G,H; 
RM-ANOVA, trial*drug interaction; log power: F(1,9) = 0.39, p = 0.25; S2N: F(1,9) = 0.23, p = 0.37). Hence, anal-
ysis of power spectra indicated that modulating the activity of MS cholinergic neurones in this way reduced the 
frequency of LFP theta oscillations without changing their power.
The frequency of theta oscillations vary as a function of the animal’s running speed38,39. We therefore analysed 
what impact the DREADD manipulation of cholinergic activity had on the theta frequency vs running speed 
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Figure 1. Modulating medial septal cholinergic activity reduces LFP theta frequency by shifting its relationship 
with running speed to lower frequencies. (A) Schematic representation of the experiment design: the Cre-
dependent excitatory DREADD hM3Dq was injected into the medial septum of ChAT-Cre mice. In the same 
animal, tetrodes were implanted in the medial entorhinal cortex. (B) 2.5x epifluorescence images of coronal 
brain sections showing ChAT expression (green) and mCherry expression (red), with expression of the latter 
limited to the medial septum. (C) 40x confocal z-stack images demonstrating tight overlap between ChAT 
and mCherry expression. (D) Average LFP power spectra: mean ± SEM log power at each frequency across 
all baseline, CNO, and saline probe trials respectively. (E) Mean ± SEM frequency of maximum power in the 
3–11 Hz range at each running speed, averaged across all baseline, CNO, and saline probe trials respectively. 
(F–K) Blue = CNO, black = saline. Bars indicate mean ± SEM across all animals in each group. Crosses indicate 
average value for each animal in each group. Stars indicate RM-ANOVA baseline vs probe * CNO vs saline 
interaction significance. ***p < 0.001, **p < 0.01, *p < 0.05, ns = p > 0.05. (F) Frequency of maximum power 
in the LFP power spectrum in the theta (6–10 Hz) band. (G) Maximum log power in the theta band of the LFP 
power spectrum. (H) Theta S2N: the ratio of average power in a 2 Hz window around the theta peak compared 
to average power in the rest of the 3–25 Hz range. (I–K) Three-term exponential fit parameter A, B, and C values 
respectively that best fitted the LFP theta frequency vs running speed relationship.
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relationship. Wavelets were used to generate instantaneous estimates of the LFP power spectrum, which were 
combined to provide average power spectra in running speed bins of width 0.25 cm/s from 0–30 cm/s. For each 
speed bin the frequency of maximum power in a broad theta-band (3–11 Hz) was identified. The theta frequency 
vs running speed relationship consistently appeared to be non-linear (Fig. 1E, Supp Fig. 2A). Analysis of artificial 
LFP traces confirmed this was not an artefact of the analysis procedure (Supp Fig. 2B). The data were therefore 
fit with both linear (y = A + B * x) and three-term exponential (y = A − B ∗ e[−C ∗ x]) functions using linear and 
non-linear least squares respectively, and the F-test used to assess whether there was a significant difference in the 
quality of the fits. In 100% of the 95 baseline, CNO, and saline probe trials performed, the exponential fit was sig-
nificantly better (all p < 0.001); subsequent analyses of theta frequency vs running speed assume the non-linear 
fit. Following injection of CNO, the average theta frequency vs running speed relationship was shifted to lower 
frequencies (Fig. 1E). This change was reflected in a significant reduction in the parameter A value which best fit-
ted the theta frequency vs running speed relationship (Fig. 1I; RM-ANOVA, trial*drug interaction; F(1,9) = 37.42, 
p = 0.00018). In contrast, there was no significant effect of CNO on Parameter B or C (Fig. 1J,K; RM-ANOVA, 
trial*drug interaction; Parameter B: F(1,9) = 1.15, p = 0.31; parameter C: F(1,9) = 0.0044, p = 0.95). Alteration of 
the excitability of MS cholinergic neurones therefore decreased the frequency of theta oscillations by reducing 
the average frequency observed at each running speed, without affecting the shape of the non-linear relationship 
between the animal’s running speed and theta frequency.
Theta oscillations can also be observed in the bursts of action potentials emitted by individual neurones of 
the medial entorhinal cortex40. We therefore asked whether modulating the excitability of MS cholinergic neu-
rones affected the theta bursting of single units. The theta-band modulation of cells’ firing was quantified from 
the power spectra of the temporal autocorrelogram of each neurone’s spike train. Theta modulated cells were 
defined as those whose signal to noise ratio (S2N: ratio of average power in 2 Hz band centred on the theta peak 
to average power in the rest of the 3–25 Hz range) was greater than that seen in 99/100 shuffles where spike times 
were randomly set. Only a small number of grid cells were significantly theta modulated (27 out of 227 baseline 
and probe grid cell trials [11.95%], 11.86% of baseline trials, 10.34% of CNO probe trials, 14.00% of saline probe 
trials, Supp Fig. 5B). The small number of grid cell trials with significant theta modulation precluded full analysis 
or hypothesis testing of the effect of CNO on the temporal aspects of their firing, and we therefore instead focused 
on a larger population of theta modulated non-spatial cells (125 out of 145 baseline and probe trials with signifi-
cant theta modulation [86.21%], Supp Fig. 5A). As in the LFP, after injection of CNO, the theta burst frequency of 
these cells was reduced, without change in the strength of theta modulation (Fig. 2A–C; RM-ANOVA, trial*drug 
interaction; frequency: F(1,6) = 30.934, p = 0.0014; S2N: F(1,6) = 0.20, p = 0.67). The relationship between theta 
burst frequency and running speed was also assessed. To do so, power spectra generated from the temporal auto-
correlograms of spike trains seen in 2 second windows across the trial were averaged together into 4 cm/s speed 
bins, with the theta frequency of maximum power identified in each bin. Administration of CNO shifted the 
speed-frequency relationship downwards (Fig. 2D). Again, this change corresponded to a reduction in parameter 
A of the exponential fit, whereas no change was seen in parameters B and C (Fig. 2E–G; RM-ANOVA, trial*drug 
interaction; parameter A: F(1,3) = 40.40, p = 0.008, parameter B: F(1,3) = 3.66, p = 0.15; parameter C: F(1,3) = 5.97, 
p = 0.092). The same conclusions were reached when averaging at the level of cell rather than animal, to increase 
the number of data points (Supp Fig. 5C–G). Hence, as in the LFP, modulation of septal cholinergic activity 
reduced the burst frequency of theta modulated neurones by shifting the theta frequency vs running speed rela-
tionship to lower frequencies, without affecting the depth of theta frequency modulation across different speeds.
At the start of trials following injection of CNO, mice displayed a pattern of behaviour normally seen dur-
ing exposure to novel environments. In the first five minutes of CNO probe but not saline probe trials, mice 
exhibited a clear tendency to run predominantly around the perimeter of the environment (Fig. 3A). Indeed, 
injection of CNO led to a significant increase in the proportion of the first five minutes of the trial that mice 
spent within 10 cm of the walls of the enclosure (‘perimeter dwell’, Fig. 3B; RM-ANOVA, trial*drug interac-
tion; F(1,9) = 17.103, p = 0.0025), and not moving (Fig. 3C; RM-ANOVA, trial*drug interaction; F(1,9) = 7.251, 
p = 0.025). These changes were seen despite there being no effect of CNO on the average running speed across 
the trial (Fig. 3D; RM-ANOVA, trial*drug interaction, F(1,9) = 0.11, p = 0.75). There was also no difference in the 
average distribution of running speeds across CNO and saline probe trials (Fig. 3E; Kolmogorov-Smirnov test, 
p = 0.998). Therefore, in addition to modulating theta frequency, alteration of the excitability of MS cholinergic 
neurones also led mice to spend a greater proportion of the beginning of subsequent trials near the perimeter of 
the enclosure and not moving.
Three control animals transfected with the fluorophore virus AAV2-hSyn-DIO-mCherry were exposed 
through intraperitoneal injections to 1, 3, and 5 mg/kg doses of CNO, and equivalent volumes of saline. In con-
trast to mice injected with the hM3Dq virus, no effect of CNO was observed on peak LFP theta frequency (Supp 
Fig. 3A), LFP theta frequency vs running speed exponential fit parameter A (Supp Fig. 3B), perimeter dwell 
(Supp Fig. 3C), or the proportion of time spent sitting still (Supp Fig. 3D). Mixed model ANOVA (with hM3Dq 
vs DIO-mCherry control animals as a between-subject factor, and baseline vs CNO probe vs saline probe as a 
within-subject factor) were used to assess whether the change in these measures between drug conditions differed 
between hM3Dq and control mice. Indeed, significant interaction terms indicated a clear difference between 
hM3Dq and control mice in the change in exponential fit parameter A and perimeter dwell values across drug 
conditions (Supp Fig. 3J,K; MM-ANOVA mouse-type*drug interaction; parameter A: F(2,10) = 12.37, p = 0.0019; 
perimeter dwell: F(2,10) = 5.90, p = 0.020). The interaction effects for peak theta frequency and time spent still 
were not significant however (Supp Fig. 3I–L; MM-ANOVA mouse-type*drug interaction peak theta frequency: 
F(2,10) = 2.17, p = 0.165; time still: F(2,10) = 1.16, p = 0.35), probably due to the relatively low power of the statistical 
test (experiments were only performed on three control mice) and the relatively poorer and more variable behav-
iour of the control mice: in contrast to the hM3Dq mice, the controls were food restricted for a shorter period and 
less thoroughly behaviourally trained, as extensive coverage of the enclosure was not required given the absence 
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of grid cell recordings, potentially affecting measures sensitive to the animal’s running behaviour, including peak 
theta frequency and time sitting still. No dose-dependent effects were observed in the control mice across these 
same four measures between the 1, 3, and 5 mg/kg concentrations of CNO administered (Supp Fig. 3E–H). The 
Figure 2. Modulating medial septal cholinergic activity reduces the burst frequency of theta-modulated 
non-spatial cells. (A) Example power spectra indicating the power at each frequency in the 3–25 Hz range in 
temporal autocorrelograms of spike trains from two theta-modulated single units. Left: a unit in a baseline 
trial and the same unit in a CNO probe trial. Right: a unit in a baseline trial and the same unit in a saline probe 
trial. Inset: smoothed spike train temporal autocorrelograms from the same cells/trials from which the power 
spectra were derived. (B,C,E–G) Blue = CNO, black = saline. Bars indicate mean ± SEM across all animals in 
each group. Crosses indicate average value for each animal in each group. Stars indicate RM-ANOVA baseline 
vs probe * CNO vs saline interaction significance. ***p < 0.001, **p < 0.01, *p < 0.05, ns = p > 0.05. (B,C) 
Only cells with significant theta modulation (assessed by a shuffle procedure) in either a baseline or probe trial 
are included. (B) Theta burst frequency of single units, as inferred from the frequency of maximum power 
in the 6–10 Hz theta window of each unit’s power spectrum. (C) Theta S2N: the ratio of average power in a 
2 Hz window around the theta peak compared to average power in the rest of the 3–25 Hz. (D) Mean ± SEM 
unit burst frequency of maximum power in the 3–11 Hz range in each running speed bin, averaged across all 
baseline, CNO, and saline probe trials with significant theta modulation respectively. (E–G) Parameter A, B, and 
C values respectively that best fit the single unit theta frequency vs running speed relationship. Only cells with 
significant theta modulation (assessed by a shuffle procedure) in either a baseline or probe trial, and only trials 
with a significantly better exponential than linear fit are included.
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changes observed in animals injected with the hM3Dq virus cannot be explained by the fact that CNO probe tri-
als always followed saline probe trials on ‘dual-drug’ days in which both saline and CNO probe trials were carried 
out: when only data from days in which only either a CNO or saline probe trial were performed, with the order 
of days counterbalanced between animals, all significant results were maintained (Supp Fig. 4). These data thus 
give credence to the conclusion that the effects described here result from modulation of the excitability of MS 
cholinergic neurones, arising from CNO acting on exogenously expressed hM3Dq receptors, rather than through 
either CNO or Clozapine acting on endogenous receptors.
Grid cells were recorded in 7 of the 10 mice. A cell was classified as a grid cell if it exhibited hexagonally 
periodic spatial firing (gridness score > 0.3 in either a baseline or probe trial). Following injection of CNO, little 
change was observed when comparing ratemaps of the same grid cells between baseline and CNO probe tri-
als (Fig. 4A). Indeed, there was no significant change in gridness scores measured following injection of CNO 
(Fig. 4B; RM-ANOVA, trial*drug interaction; F(1,6) = 1.05, p = 0.34). Neither was there a significant effect on 
grid scale, when looking at cells with gridness > 0.3 in both a baseline and probe trial (Fig. 4C; RM-ANOVA, 
trial*drug interaction; F(1,5) = 0.021, p = 0.89). In analysing whether CNO affected the intra-trial stability of 
grid-patterns, bin-wise Pearson correlations were calculated between ratemaps corresponding to the first and sec-
ond half of each trial; no effect of CNO was observed (Fig. 4D; RM-ANOVA, trial*drug interaction; F(1,6) = 0.75, 
p = 0.42). Similarly, we assessed the inter-trial stability of grid cells using the same procedure to compare baseline 
ratemaps with saline and CNO probe trials. CNO was not found to affect the spatial stability of grid firing across 
trials (Fig. 4E; paired t-test, t6 = −0.38, p = 0.72). The same conclusions were reached when averaging at the level 
of cell rather than animal to increase the number of data points (Supp Fig. 6A,B). That is, while altering septal 
cholinergic activity modulated theta frequency and behaviour, no effect was seen on grid cell firing patterns.
Given the absence of change in grid cell firing patterns, we asked whether modifying MS cholinergic activity 
affected putative speed signals seen in grid cells. First, we analysed changes in the firing rates of grid cells seen as a 
function of running speed. Specifically, following Kropff et al. 2015 41, we calculated the instantaneous firing rate 
of each grid cell, using linear regression to identify the slope and correlation (‘speed score’) of its relationship with 
running speed. A grid cell was identified as significantly speed modulated if, in either a baseline or probe trial, 
it had both gridness > 0.3 and a speed score exceeding 99% of a null distribution of 1000 speed scores generated 
Figure 3. Modulating medial septal cholinergic activity results in a pattern of behaviour normally seen 
during exposure to novel environments. (A) Cumulative position plots from two animals (one in each row), 
indicating coverage of the environment in the first five minutes of baseline, CNO, and saline probe trials. (B–D) 
Blue = CNO, black = saline. Bars indicate mean ± SEM across all animals in each group. Crosses indicate 
average value for each animal in each group. Stars indicate RM-ANOVA baseline vs probe * CNO vs saline 
interaction significance. ***p < 0.001, **p < 0.01, *p < 0.05, ns = p > 0.05. (B) Proportion of the first five 
minutes of the trial spent within 10 cm of the walls of the enclosure (‘perimeter dwell’). (C) Proportion of the 
first five minutes of the trial spent sitting still (running speed < 1 cm/s). (D) Mean running speed across the 
whole trial. (E) Mean ± SEM proportion of the whole trial spent at each 2 cm/s speed bin across all baseline, 
CNO, and saline probe trials respectively.
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Figure 4. Modulating medial septal cholinergic activity has no effect on grid cell firing patterns. (A) Example 
ratemaps and spatial autocorrelograms from four grid cells (one in each row), in a baseline trial (left hand side) and 
a CNO probe trial (right hand side). (B–E) Blue = CNO, black = saline. Bars indicate mean ± SEM across all animals 
in each group. Crosses indicate average value for each animal in each group. Only cells with gridness > 0.3 in either a 
baseline or probe trial are included. (B–D) Stars indicate RM-ANOVA baseline vs probe * CNO vs saline interaction 
significance. ***p < 0.001, **p < 0.01, *p < 0.05, ns = p > 0.05. (B) Degree of hexagonal regularity of grid cell 
firing patterns, as measured by the gridness score. (C) Grid cell scale in cm, measured as the median distance to the 
six peaks closest to the centre of the autocorrelogram. Only trials with gridness > 0.3 are included. (D) Intra-trial 
stability of grid cell firing patterns, as measured by the value at the centre of a cross-correlogram constructed from 
two ratemaps, one from each half of the trial. (E) Inter-trial stability of grid cell firing patterns, as measured by the 
value at the centre of a cross-correlogram constructed from two ratemaps, one from the baseline and one from the 
probe trial. No significant difference was found between the groups using a paired t-test.
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by randomly permuting its spike train relative to the animal’s running speed. No effect of CNO could be seen in 
the binned average firing rate vs running speed plots of speed modulated grid cells (Fig. 5A). Indeed, in animals 
with speed modulated grid cells, there was no effect of CNO on the speed score, nor the slope of the firing rate 
vs running speed regression line (Fig. 5B,C; RM-ANOVA, trial*drug interaction; speed score: F(1,5) = 0.00079, 
p = 0.98; slope: F(1,5) = 0.41, p = 0.55). An animal’s running speed is also thought to be encoded in the difference 
in frequency of multiple theta oscillations whose frequency vs speed relationship have differing slopes18. This 
encoding mechanism is thought to manifest as theta phase precession, the tendency of grid cells to fire at earlier 
phases of the theta cycle as the animal moves through grid fields42, and we therefore asked whether theta phase 
precession was affected by administration of CNO. Following CNO injection, theta phase precession could still 
be observed in grid cells (Fig. 5D), and there was no effect on the correlation or slope of grid cells assessed as 
significantly phase precessing by a shuffle procedure (Fig. 5E,F; RM-ANOVA, trial*drug interaction; F(1,3) = 1.10, 
p = 0.38; F(1,3) = 1.51, p = 0.31). Repeating the speed modulation and phase precession analyses averaging at the 
level of cell (rather than animal) to increase the number of data points did not change these conclusions (Supp 
Fig. 6C–F). The absence of change in grid cell firing patterns was therefore consistent with a lack of change in 
putative speed signals in grid cells following modulation of MS cholinergic tone.
Figure 5. Modulating medial septal cholinergic activity has no effect on putative grid cell speed signals. (A) 
Mean ± SEM firing rate of grid cells as a function of running speed, averaged across all baseline, CNO, and 
saline probe trials respectively. Only grid cell trials with significant speed modulation (determined by a shuffle 
procedure) are included. (B,C,E,F) Blue = CNO, black = saline. Bars indicate mean ± SEM across all animals in 
each group. Crosses indicate average value for each animal in each group. Stars indicate RM-ANOVA baseline 
vs probe * CNO vs saline interaction significance. ***p < 0.001, **p < 0.01, *p < 0.05, ns = p > 0.05. (B,C) Only 
grid cells with significant speed modulation in either a baseline or probe trial are included. (B) Grid cell speed 
scores: the Pearson correlation between a cell’s instantaneous firing rate and the animal’s running speed. (C) 
Grid cell speed slope: the slope of the regression line which best fitted the relationship between instantaneous 
firing rate and running speed. (D) Two example CNO probe trials in which significant grid cell phase precession 
was seen. One cell is plotted in each row. Left-hand side: smoothed firing rate map, with crosses indicating 
field peaks. Centre: Watershed-isolated valid fields. Right: scatter of theta phase as a function of proportion of 
distance along run through the field. Red line indicates best fitting circular-linear regression slope. (E,F) Only 
grid cells with significant phase precession in either a baseline or probe trial are included. (E) Circular-linear 
correlation values relating theta phase to proportional distance through the field. (F) The slope of the circular-
linear phase precession regression line.
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Discussion
Aiming to illuminate the contribution of cholinergic neurones to the septum’s theta rhythmogenesis, its encoding 
of running speed, and its support of grid cell firing, we modulated the activity of MS cholinergic neurones while 
recording local field potentials and from single units in the medial entorhinal cortex of freely foraging mice. 
Using DREADDs to modulate the excitability of septal cholinergic cells reduced theta frequency by shifting its 
saturating-exponential relationship with running speed to lower frequencies, and led mice to exhibit behaviours 
at the start of trials normally seen on exposure to novel environments. Despite these changes, no effect was seen 
on grid cell firing patterns, consistent with a lack of change in either the theta-frequency or firing-rate speed 
signals potentially used by grid cells.
A reduction in theta frequency following modulation of cholinergic activity is consistent with evidence 
demonstrating that application of the muscarinic receptor agonist carbachol reduces the frequency of sub-
threshold membrane potential oscillations43, and resonance44, of medial entorhinal layer-II stellate cells in-vitro. 
Through application of the acetylcholinesterase-inhibitor physostigmine, similar results have also been observed 
in-vivo45. Blockade of muscarinic receptors with systemic administration of scopolamine has also been observed 
to reduce theta frequency in behaving animals, though in contrast to the present results, through a flattening of 
the theta frequency vs running speed slope24. Further, lesions specifically targeting MS cholinergic neurones have 
been found to reduce the power of theta oscillations without affecting their frequency21,22. The current results 
therefore complement a growing body of evidence demonstrating a role for MS cholinergic neurones in modu-
lating movement-related theta oscillations, though one in which their precise functional contribution remains 
unclear. Some variability in the described results likely stems from differences in the techniques employed both to 
modulate cholinergic tone and record theta. For example, recording in the hippocampus rather than the entorhi-
nal cortex may lead to observation of a change in power without a change in frequency of theta oscillations, 
because of an absence of the stellate cells whose subthreshold oscillatory dynamics are modulated by acetylcho-
line44. Similarly, non-linear responses to acetylcholine concentration, as well as adaptation over time, may mean 
that the impact of any intervention depends on whether it increases or decreases cholinergic tone, is acute or 
chronic. Further experiments are also required to identify whether the observed reduction in theta frequency is 
due to local connections of cholinergic neurones within the MS, or direct projections to the entorhinal cortex.
The strongly non-linear relationship between theta frequency and running speed observed here is unlikely 
to be an artefact of the analysis, as the same procedure was capable of correctly identifying linear and sinusoidal 
relationships in artificially-generated data. Further, though not remarked upon, a number of observations of 
non-linear increases in theta frequency have been made in the past24,39,46; though, to the best of our knowledge, 
this is the first explicit quantification of the non-linearity. The saturating-exponential relationship consistently 
observed here means that the fastest rate of change in theta frequency is seen at the lowest running speeds. It 
is possible that this rapid change in frequency represents a transition between immobility-related Type II, and 
movement-related Type I theta. However, in the current data, analysis using narrow-width (0.25 cm/s) speed 
bins consistently indicated a smooth increase in frequency, rather than a discontinuous jump between low- and 
high-frequency theta states. It is worth nothing that oscillatory interference models require that the differences 
in the frequencies of the constituent oscillators vary linearly with running speed, but not necessarily that the LFP 
speed-frequency relationships themselves be linear47.
Despite the observed effects on theta frequency, no change was seen in the firing patterns of recorded grid cells. 
The consistency of grid firing patterns was concordant with an absence of change in both the theta-frequency and 
firing-rate running speed signals thought used to update grid firing. The lack of change in these running speed 
codes suggests that such activity does not acutely depend on septal cholinergic neurones. Given the profound 
disruption of these signals during inactivation of the MS16,17,32, the present data instead imply that such functions 
depend on GABAergic or glutamatergic septal circuits. The absence of change in these signals prevent conclusions 
being drawn regarding the alternative hypotheses of oscillatory interference and continuous attractor models as 
to which of these two speed codes is central to the updating of the grid firing. In the present experiment, modu-
lating septal cholinergic activity had no effect on the depth of modulation of theta frequency seen as a function of 
running speed, in contrast to the flatter profile seen following systemic administration of the muscarinic receptor 
antagonist scopolamine48. This difference may explain why little change was seen here in grid cell firing patterns, 
in contrast to the breakdown of periodic firing previously reported48. The cause of the contrasting effects of 
acetylcholine manipulations on the theta frequency slope between the present and previous studies remains to 
be seen, but may relate to scopolamine acting as a global antagonist of cholinergic function, in contrast to the 
targeted modulation of septal cholinergic neurones used here. Alternatively, as noted, without direct recordings of 
cholinergic neurones in the present study, it remains equivocal what effect the DREADD manipulation ultimately 
had on cholinergic firing, and this inconsistency may result from differences in the net effect and time course the 
alternative interventions have on septal cholinergic tone.
The tendency of rodents to remain still and avoid the centre of a novel open enclosure has long been used as 
a test to identify anxiolytic effects of drugs49, while electric shocks have been shown to increase rats’ tendency to 
‘freeze’, and remain near the perimeter of novel environments50. As such, these freezing and ‘thigmotactic’ behav-
iours are closely associated with both novelty and anxiety. In the current experiment, the increased proportion 
of time spent in the periphery of the enclosure and not-moving cannot be accounted for by an anxiogenic effect 
of the intraperitoneal injection alone, as the increase in both measures seen following injection of CNO was 
significantly greater than that seen following injection of saline. Interestingly, the reduction in theta frequency 
here is similar to that observed following injection of anxiolytic drugs in rats51, while the behavioural changes are 
redolent of anxiogenesis or novelty. Acetylcholine is closely related to learning and memory52,53, and observed 
increases in cholinergic tone in novel contexts54 are thought to drive the encoding of new memories in the hip-
pocampal formation52. The novelty-like behaviours seen here after modulating the activity of MS cholinergic 
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neurones could therefore be interpreted as the result of inducing a sense of novelty in the mice, though the cur-
rent data cannot distinguish this interpretation from an increase in anxiety.
The Cre-dependent virus used here meant that the DREADD hM3Dq was expressed exclusively in choliner-
gic neurones of the MS. hM3Dq has been widely used as a neuroscientific tool, as injection of its agonist CNO 
leads to an increase in the excitability of hM3Dq expressing neurones35 (though likely only after conversion to 
Clozapine36). Indeed, activation of hM3Dq receptors by CNO can lead neurones to emit bursts of action poten-
tials35. However, the effect of this manipulation on the activity patterns of the slow-firing cholinergic neurones of 
the MS55 remains to be seen. Further, given that septal cholinergic neurones are interconnected with other neural 
subgroups of the MS, including GABAergic neurones37,56, the ultimate effect on the activity of both cholinergic 
and non-cholinergic components of the MS circuitry of the hM3Dq manipulation in the present experiment is 
unknown. Indeed, in certain neurones, using genetic tools to elicit extended excitation has been shown to lead to 
reduced firing, for example through depolarising block57. As such, while the robust effects of this manipulation 
on both theta oscillations and the mice’s behaviour can be inferred to arise from a perturbation of the MS net-
work that originates with the modulation of the excitability of cholinergic neurones, without direct recordings 
from septal neurones, the precise nature of the intervention remains uncertain. While beyond the scope of the 
current experiment, fibre-photometry or optogenetic-tagging could be used to record from specific neural sub-
groups of septal neurones, such that the effect of CNO administration on each genetic subtype in the MS could 
be identified.
In sum, the data presented here provide evidence for a role of MS cholinergic neurones in modulating 
movement-related theta oscillations, particularly in determining their frequency. Further, an increase in time sit-
ting still and an avoidance of the centre of the environment suggests that the DREADD manipulation of choliner-
gic neurones gave rise to a sense of novelty or anxiety. In comparison to the profound effect of MS inactivation on 
theta oscillations5,6, firing-rate speed signals32, and grid cell firing16,17, the preservation of these neural processes 
in the present data suggest they do not acutely depend on septal cholinergic neurones, and thus that they may 
instead arise principally from the activity of GABAergic or glutamatergic cells in the MS. However, to confirm 
whether the present data’s suggestion of this hypothesis is valid, one would ideally selectively and bidirectionally 
modulate the activity of septal cholinergic neurones. In this experiment, a lack of direct recordings however 
means that the net effect of the DREADD manipulation on the activity of both cholinergic and non-cholinergic 
neural subgroups of the MS remains uncertain.
Methods
A full account of the methods and analyses employed is provided in the Supplementary Information section.
All work was conducted within the terms of appropriate Project and Personal Licenses approved by University 
College London and the UK Home Office. 13 ChAT-IRES-Cre mice were injected in the medial septum (0.7–
0.9 mm anterior to bregma, 0.8mm lateral to bregma, 12° angle towards midline, 4 × 300 nl injections at 4.3, 3.9, 
3.5 and 3.1 mm ventral from brain surface) with the Cre-dependent virus AAV2-hSyn-DIO-hM3D(Gq)-mCherry 
or the control virus AAV2-hSyn-DIO-mCherry. Two microdrives, each containing four tetrodes, were implanted 
bilaterally in the medial entorhinal cortex (3.2 mm lateral to lambda, 0.3–0.5 mm anterior to the anterior edge 
of the transverse sinus, 6° angle in the posterior direction, 0.8–1 mm below brain surface) in the same animals.
At least three weeks after surgery, single-unit and local field potential recordings were made while mice 
explored familiar 90 × 90 cm square or 1 m diameter circular environments. In seven of the 10 hM3Dq mice, 
screening was continued until grid cells were recorded. In three of the hM3Dq and the three control-mCherry 
mice, no grid cells were recorded, and the experiment was commenced while large amplitude theta oscillations 
could be observed in the LFP. On ‘single drug’ experimental days, following a baseline trial, mice were injected 
intraperitoneally with 3 mg/kg of Clozapine-N-Oxide(CNO) or an equivalent volume of saline. That is, on single 
drug days, either CNO or saline was injected, with the order of the drugs across days counterbalanced between 
animals. One hour after the injection, a second trial was recorded, termed a ‘CNO probe’ or ‘saline probe’ trial. In 
addition, four mice also had recordings made under a ‘dual drug’ protocol. Here, following the baseline trial, the 
mouse was first injected with saline, and after a one hour break, a saline probe trial was recorded. Subsequently, 
the mouse was then injected with CNO, and after a second one hour break, a CNO probe trial was recorded. Dual 
drug days thus included three trials, with the saline probe trial always leading the CNO probe trial due to the 
long-lasting time course of CNO action. The experimental protocol is pictorially represented in Supplementary 
Fig. 1.
To assess whether there was a significant change in the LFP, the theta bursting of single units, the mice’s 
behaviour, or the firing patterns of grid cells, appropriate analyses described below were conducted to generate 
measures which were tested using Repeated Measures ANOVA (RM-ANOVA) at the level of animal. Concretely, 
for each measure we averaged together values from all qualifying cells and trials to generate four values for each 
animal: a CNO baseline, a saline baseline, a CNO probe, and a saline probe value. CNO and saline baselines 
were distinguished by whether they were followed by injection of either CNO or saline. The interaction term of 
the RM-ANOVA test was then used to assess the null hypothesis that there was no difference between CNO and 
saline groups in the change in each measure between baseline and probe trials. Further, Mixed Model ANOVA 
(MM-ANOVA) were used to assess whether the change in these measures between drug conditions differed 
between hM3Dq-injected experimental mice and DIO-mCherry injected control mice.
Changes in the frequency and power of LFP theta oscillations were assessed using power spectra generated 
using Welch’s method. Changes in the shape of the theta frequency vs running speed relationship were analysed 
through evaluation of the parameters in the three-term saturating exponential function y = A − B * e(−C * x) which 
best fit the theta frequency vs running speed distribution produced by binning a spectrogram created with Morlet 
wavelets into speed bins of 0.25 cm/s from 0–30 cm/s. Equivalent analyses of the theta bursting of single units were 
performed using stationary or windowed power spectra derived from the temporal autocorrelogram of each unit’s 
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spike train. Changes in the mice’s behaviour were assessed through calculation of the time spent within 10 cm 
of the borders of the enclosure, the time spent sitting still (moving < 1 cm/s), and the average running speed. 
Changes in the firing patterns of grid cells were assessed through calculation of gridness and scale values from the 
spatial autocorrelogram of each unit’s firing rate map. Each grid cell’s inter and intra trial stability were assessed 
using spatial cross-correlograms between the baseline and probe trial, or the first and second half of the each 
trial respectively. The speed modulation and phase precession of grid cells were assessed following Kropff et al.41  
and Jeewajee et al. 42 respectively.
Following completion of the experiments, immunohistochemical analysis was performed on coronal brain 
slices to assess expression of ChAT and mCherry. Slices were imaged to determine the extent of viral expres-
sion, and manual cell counting was performed to measure the overlap between neurones expressing ChAT and 
mCherry across the entire septum.
Data and code sharing. The authors will make the data and MATLAB analysis code used available upon 
reasonable request.
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